Oxidative stress in diabetic retinopathy

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 5, 2011, Pages 994-997

  Vidya, Desai ^a   Shekhar, Ravi ^a   Prabodh, Siva ^a   Chowdary, N V S ^a   Das, M C ^a   Joji Reddy, M ^a  

^a NRI Medical College   (India)

Author keywords

HbA1c; MDA; Oxidative stress; Vitamin C

Indexed keywords

ASCORBIC ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALONALDEHYDE BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 80054765617     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gupta M.M, Chari S. Lipid peroxidation and the antioxidant status in patients with diabetic retinopathy. Indian J Physiol Pharmacol 2005; 49(2):187-192.
2. Soliman GZA. Blood lipid per oxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J 2008; 49(2):129-136.
3. Gupta S, Ambade A. Prevalence of diabetic retinopathy and influencing factors amongst type 2 diabetics from central India. Int.J.Diab.Dev. Countries 2004; 24:75-78.
4. Klein R, Klein BE, Moss SE, Davis MD, Demets DL. Glycosylated hemoglobin predicts the incidence and the progression of Diabetic retinopathy. J Am Med Assoc 1988; 260:2864-71.
5. Draper HH, Hadley M. Malondialdehyde determination as an index of lipid per oxidation. Methods Enzymol 1990; 186:421-431.
6. Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL. et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 2004; 45:910-18.
7. Kurtul N, Bakan E, Hiilya A, Baykal. Leukocyte lipid peroxidation, superoxide dismutase and the catalase activities of type 2 diabetic patients with retinopathy. Acta Medica 2005;48(1):35-38.
8. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer I, et al. The role of oxidative stress in the onset and progression of diabetes and its complications. Diabetes Met ab Res Rev 2001; 17:189-212.
9. Philips M, Cataneo RN, Cheema T, Greenberg J. Increased breath biomarkers of oxidative stress in diabetes mellitus. Clinica Chimica Acta 2004; 344:189-194.
10. Unger J. Reducing oxidative stress in patients with Type 2 Diabetes Mellitus: A preliminary care cell to action. Insulin 2008; 3:176-184.
11. Wolff SP, Dean RT. Glucose auto oxidation and protein modification potential role of 'auto oxidative glycosylation' in diabetes. Biochem J 1987; 245:245-50.
12. Murat Y, Ayhan K, Nuri C, Füsun T, Ersel D, lhan Y, Göksun A, Metin A.The effects of vitamin E on oxidative stress and the metabolic status in Diabetes mellitus. Turkiye Klinkleri J Endocrin 2004; 2:200-205.
13. Kumari S, Panda S, Mangaraj M, Mandal MK, Mahapatra PC. Plasma MDA and antioxidant vitamins in Diabetic Retinopathy. Indian J Clin Biochem 2008; 23:158-162.
14. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis D, LaPorte RE, Kuller LH, Wolfson SK, Drash AL. Factors which are associated with the avoidance of severe complications after 25 yrs of IDDM. The Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 1990; 13:741-747.
15. Trinder P. Determination of glucose by using the glucose oxidase method with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6:24-27.